CLEVELAND, Ohio – Moderna is developing a two-in-one vaccine booster shot that protects against both COVID-19 and flu, and U.S. COVID-19 cases have reached 40 million.
Cleveland.com is rounding up some of the most notable coronavirus news making headlines online. Here’s what you need to know for Friday, Sept. 10.
Moderna working on flu-COVID-19 combo booster shot
Moderna is developing a two-in-one vaccine booster shot that protects against both COVID-19 and seasonal influenza, the pharmaceutical company announced Thursday.
The new vaccine, called mRNA-1073, combines Moderna’s current COVID-19 vaccine with a flu shot that’s also under development, according to a press release.
“Today we are announcing the first step in our novel respiratory vaccine program with the development of a single dose vaccine that combines a booster against COVID-19 and a booster against flu,” CEO Stephane Bancel said in a statement Thursday.
More than 147 million of the Moderna shots have been administered in the United States, according to the U.S. Centers for Disease Control and Prevention.
U.S. COVID-19 cases reach 40 million
There have been 40 million cases of COVID-19 recorded in the United States — nearly one-fifth of all cases worldwide — according to a database compiled by the New York Times.
As of Sunday there have been an average 161,000 new cases of COVID-19 in this country each day, according to news reports. Hospitalizations are about 102,000 each day, and the daily COVID-19 death toll is now at 1,560.
No U.S. state has yet gotten more than 70% of its residents fully vaccinated, according to the New York Times.
U.S. children now more than one quarter of new weekly COVID-19 cases
For the first time during the pandemic, American children now account for more than one quarter of new weekly COVID-19 cases, according to the American Academy of Pediatrics.
Nearly 252,000 pediatric COVID-19 cases were reported for the week ending Sept. 2, the largest number recorded for children during the pandemic, according to the report. Children accounted for 26.8% of reported weekly cases in this country.
“After declining in early summer, child cases have increased exponentially, with over 750,000 cases added between Aug. 5 and Sept. 2,” the American Academy of Pediatrics.
Hospitalization and death are still rare in children, the academy said. But more pediatric COVID-19 cases are likely with the surging delta variant and schools opening for fall.
Pfizer antibodies decrease in nursing home residents and caregivers, study suggests
Six months after senior nursing home residents and their caregivers received their second dose of the Pfizer vaccine, the COVID-19 antibodies the vaccine produced decreased more than 80%, a new study suggests.
The research, led by Case Western Reserve University and Brown University, studied blood samples of 120 nursing home residents and 92 health care workers. The study, posted on the preprint server medRxiv, has not be published.
Researchers found that antibody levels decreased more than 80 percent after six months. The results were the same in seniors, with a median age of 76, and caregivers, with a median age of 48, the study found.
By six months after vaccination, the blood of 70 percent of these nursing home residents had “very poor ability to neutralise the coronavirus infection in laboratory experiments,” said David Canaday, an associate professor at CWRU.
Your coronavirus vaccine questions answered:
— to www.cleveland.com